Skip to main content
Erschienen in: Acta Diabetologica 8/2019

19.04.2019 | Original Article

Serum levels of immunoglobulin G and complement 3 differentiate non-diabetic renal disease from diabetic nephropathy in patients with type 2 diabetes mellitus

verfasst von: Junlin Zhang, Yiting Wang, Rui Zhang, Hanyu Li, Qianqian Han, Yucheng Wu, Shanshan Wang, Ruikun Guo, Tingli Wang, Li Li, Fang Liu

Erschienen in: Acta Diabetologica | Ausgabe 8/2019

Einloggen, um Zugang zu erhalten

Abstract

Aims

Heavy proteinuria caused by non-diabetic renal disease (NDRD) is common in type 2 diabetes mellitus (T2DM). The aim of this study was to investigate specific predictors for NDRD in addition to traditional indicators in T2DM.

Methods

A total of 341 patients with T2DM who underwent renal biopsy were retrospectively included. Eligible patients were divided into a nephrotic-range group (n = 194) and a non-nephrotic-range group (n = 147) based on proteinuria level. Risk factors for NDRD were evaluated using logistic regression, and the diagnostic implications of these variables were assessed by subgroup.

Results

Multivariate logistic regression indicated that serum IgG level (OR, 0.762; 95% CI, 0.628–0.924; p = 0.006) was an independent predictor of NDRD in the nephrotic-range group. However, in the non-nephrotic-range group, increased C3 level was an independent risk factor for NDRD (OR, 1.313; 95% CI, 1.028–1.678; p = 0.029). In the nephrotic-range group, the optimal cutoff value of IgG for predicting NDRD was 734.0 mg/dl, with 67.8% sensitivity and 74.8% specificity, and IgG ≤ 734.0 mg/dl was the best predictor of NDRD. In the non-nephrotic-range group, the optimal cutoff value of C3 for predicting NDRD was 122.0 mg/dl with low sensitivity (30.9%) but high specificity (97.8%).

Conclusions

At different levels of proteinuria, reduced IgG and increased C3 levels were independent indicators of NDRD in T2DM. Insights into these factors will help to advance the clinical management of NDRD.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Fiorentino M, Bolignano D, Tesar V, Pisano A, Biesen WV, Tripepi G et al (2017) Renal biopsy in patients with diabetes: a pooled meta-analysis of 48 studies. Nephrol Dial Transplant 32:97–110CrossRefPubMed Fiorentino M, Bolignano D, Tesar V, Pisano A, Biesen WV, Tripepi G et al (2017) Renal biopsy in patients with diabetes: a pooled meta-analysis of 48 studies. Nephrol Dial Transplant 32:97–110CrossRefPubMed
2.
Zurück zum Zitat Chang TI, Park JT, Kim JK, Kim SJ, Oh HJ, Yoo DE et al (2011) Renal outcomes in patients with type 2 diabetes with or without coexisting non-diabetic renal disease. Diabetes Res Clin Pract 92:198–204CrossRefPubMed Chang TI, Park JT, Kim JK, Kim SJ, Oh HJ, Yoo DE et al (2011) Renal outcomes in patients with type 2 diabetes with or without coexisting non-diabetic renal disease. Diabetes Res Clin Pract 92:198–204CrossRefPubMed
3.
Zurück zum Zitat Li L, Zhang X, Li Z, Zhang R, Guo R, Yin Q et al (2017) Renal pathological implications in type 2 diabetes mellitus patients with renal involvement. J Diabetes Complicat 31:114–121CrossRef Li L, Zhang X, Li Z, Zhang R, Guo R, Yin Q et al (2017) Renal pathological implications in type 2 diabetes mellitus patients with renal involvement. J Diabetes Complicat 31:114–121CrossRef
4.
Zurück zum Zitat Lee YH, Kim KP, Kim YG, Moon JY, Jung SW, Park E et al (2017) Clinicopathological features of diabetic and nondiabetic renal diseases in type 2 diabetic patients with nephrotic-range proteinuria. Medicine 96:e8047CrossRefPubMedPubMedCentral Lee YH, Kim KP, Kim YG, Moon JY, Jung SW, Park E et al (2017) Clinicopathological features of diabetic and nondiabetic renal diseases in type 2 diabetic patients with nephrotic-range proteinuria. Medicine 96:e8047CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat American Diabetes Association (2015) Standards of medical care in diabetes-2015 abridged for primary care providers. Clin Diabetes 33:97–111CrossRefPubMedCentral American Diabetes Association (2015) Standards of medical care in diabetes-2015 abridged for primary care providers. Clin Diabetes 33:97–111CrossRefPubMedCentral
6.
Zurück zum Zitat Zimmet PZ, Magliano DJ, Herman WH, Shaw JE (2014) Diabetes: a 21st century challenge. Lancet Diabetes Endocrinol 2:56–64CrossRefPubMed Zimmet PZ, Magliano DJ, Herman WH, Shaw JE (2014) Diabetes: a 21st century challenge. Lancet Diabetes Endocrinol 2:56–64CrossRefPubMed
7.
Zurück zum Zitat Dong Z, Wang Y, Qiu Q, Zhang X, Zhang L, Wu J et al (2016) Clinical predictors differentiating non-diabetic renal diseases from diabetic nephropathy in a large population of type 2 diabetes patients. Diabetes Res Clin Pract 121:112–118CrossRefPubMed Dong Z, Wang Y, Qiu Q, Zhang X, Zhang L, Wu J et al (2016) Clinical predictors differentiating non-diabetic renal diseases from diabetic nephropathy in a large population of type 2 diabetes patients. Diabetes Res Clin Pract 121:112–118CrossRefPubMed
8.
Zurück zum Zitat Erdogmus S, Kiremitci S, Celebi ZK, Akturk S, Duman N, Ates K et al (2017) Non-diabetic kidney disease in type 2 diabetic patients: prevalence, clinical predictors and outcomes. Kidney Blood Press Res 42:886–893CrossRefPubMed Erdogmus S, Kiremitci S, Celebi ZK, Akturk S, Duman N, Ates K et al (2017) Non-diabetic kidney disease in type 2 diabetic patients: prevalence, clinical predictors and outcomes. Kidney Blood Press Res 42:886–893CrossRefPubMed
9.
Zurück zum Zitat American Diabetes Association (2017) Standards of medical care in diabetes-2017 abridged for primary care providers. Clin Diabetes 35:5–26CrossRefPubMedCentral American Diabetes Association (2017) Standards of medical care in diabetes-2017 abridged for primary care providers. Clin Diabetes 35:5–26CrossRefPubMedCentral
10.
Zurück zum Zitat Tervaert TW, Mooyaart AL, Amann K, Cohen AH, Cook HT, Drachenberg CB et al (2010) Pathologic classification of diabetic nephropathy. J Am Soc Nephrol 21:556–563CrossRefPubMed Tervaert TW, Mooyaart AL, Amann K, Cohen AH, Cook HT, Drachenberg CB et al (2010) Pathologic classification of diabetic nephropathy. J Am Soc Nephrol 21:556–563CrossRefPubMed
11.
Zurück zum Zitat Weng CH, Hu CC, Yu CC, Lin JL, Yang CW, Hung CC et al (2012) Immunoglobulin G levels can predict non-diabetic renal disease in patients with type 2 diabetes mellitus. J Diabetes 4:37–40CrossRefPubMed Weng CH, Hu CC, Yu CC, Lin JL, Yang CW, Hung CC et al (2012) Immunoglobulin G levels can predict non-diabetic renal disease in patients with type 2 diabetes mellitus. J Diabetes 4:37–40CrossRefPubMed
12.
Zurück zum Zitat Ardawi MS, Nasrat HA, Bahnassy AA (1994) Serum immunoglobulin concentrations in diabetic patients. Diabet Med 11:384–387CrossRefPubMed Ardawi MS, Nasrat HA, Bahnassy AA (1994) Serum immunoglobulin concentrations in diabetic patients. Diabet Med 11:384–387CrossRefPubMed
13.
14.
Zurück zum Zitat Kalia K, Sharma S, Mistry K (2004) Non-enzymatic glycosylation of immunoglobulins in diabetic nephropathy. Clin Chim Acta 347:169–176CrossRefPubMed Kalia K, Sharma S, Mistry K (2004) Non-enzymatic glycosylation of immunoglobulins in diabetic nephropathy. Clin Chim Acta 347:169–176CrossRefPubMed
15.
Zurück zum Zitat Flyvbjerg A (2017) The role of the complement system in diabetic nephropathy. Nat Rev Nephrol 13:311–318CrossRefPubMed Flyvbjerg A (2017) The role of the complement system in diabetic nephropathy. Nat Rev Nephrol 13:311–318CrossRefPubMed
16.
Zurück zum Zitat Zhang J, Wang Y, Zhang R et al (2017) Implication of decreased serum complement 3 in patients with diabetic nephropathy. Acta Diabetol 55:31–39CrossRefPubMed Zhang J, Wang Y, Zhang R et al (2017) Implication of decreased serum complement 3 in patients with diabetic nephropathy. Acta Diabetol 55:31–39CrossRefPubMed
17.
Zurück zum Zitat Sharma SG, Bomback AS, Radhakrishnan J, Herlitz LC, Stokes MB, Markowitz GS et al (2013) The modern spectrum of renal biopsy findings in patients with diabetes. Clin J Am Soc Nephrol 8:1718–1724CrossRefPubMedPubMedCentral Sharma SG, Bomback AS, Radhakrishnan J, Herlitz LC, Stokes MB, Markowitz GS et al (2013) The modern spectrum of renal biopsy findings in patients with diabetes. Clin J Am Soc Nephrol 8:1718–1724CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Liu S, Guo Q, Han H, Cui P, Liu X, Miao L et al (2016) Clinicopathological characteristics of non-diabetic renal disease in patients with type 2 diabetes mellitus in a northeastern Chinese medical center: a retrospective analysis of 273 cases. Int Urol Nephrol 48:1691–1698CrossRefPubMedPubMedCentral Liu S, Guo Q, Han H, Cui P, Liu X, Miao L et al (2016) Clinicopathological characteristics of non-diabetic renal disease in patients with type 2 diabetes mellitus in a northeastern Chinese medical center: a retrospective analysis of 273 cases. Int Urol Nephrol 48:1691–1698CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Dong ZY, Wang YD, Qiu Q, Hou K, Zhang L, Wu J et al (2016) Dysmorphic erythrocytes are superior to hematuria for indicating non-diabetic renal disease in type 2 diabetics. J Diabetes Investig 7:115–120CrossRefPubMed Dong ZY, Wang YD, Qiu Q, Hou K, Zhang L, Wu J et al (2016) Dysmorphic erythrocytes are superior to hematuria for indicating non-diabetic renal disease in type 2 diabetics. J Diabetes Investig 7:115–120CrossRefPubMed
Metadaten
Titel
Serum levels of immunoglobulin G and complement 3 differentiate non-diabetic renal disease from diabetic nephropathy in patients with type 2 diabetes mellitus
verfasst von
Junlin Zhang
Yiting Wang
Rui Zhang
Hanyu Li
Qianqian Han
Yucheng Wu
Shanshan Wang
Ruikun Guo
Tingli Wang
Li Li
Fang Liu
Publikationsdatum
19.04.2019
Verlag
Springer Milan
Erschienen in
Acta Diabetologica / Ausgabe 8/2019
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-019-01339-0

Weitere Artikel der Ausgabe 8/2019

Acta Diabetologica 8/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.